Home/Filings/4/0001209191-22-037523
4//SEC Filing

Makara Richard 4

Accession 0001209191-22-037523

CIK 0001346830other

Filed

Jun 15, 8:00 PM ET

Accepted

Jun 16, 5:14 PM ET

Size

5.2 KB

Accession

0001209191-22-037523

Insider Transaction Report

Form 4
Period: 2022-06-15
Makara Richard
VP, Head of Accting;Controller
Transactions
  • Award

    Common Stock

    2022-06-15+7,50013,583 total
Footnotes (1)
  • [F1]Represents restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of common stock of the Issuer. The RSUs will vest on the earlier of (i) December 31, 2022, or (ii) the appointment of the Issuer's new Chief Financial Officer, subject to the Reporting Person's continued service to the Issuer as of such vesting date.

Issuer

Cara Therapeutics, Inc.

CIK 0001346830

Entity typeother

Related Parties

1
  • filerCIK 0001798130

Filing Metadata

Form type
4
Filed
Jun 15, 8:00 PM ET
Accepted
Jun 16, 5:14 PM ET
Size
5.2 KB